USANA HEALTH SCIENCES, INC. (NYSE:USNA) Files An 8-K Results of Operations and Financial Condition
Item 2.02
Results of Operations and Financial Condition.
On February 5, 2019, USANA Health Sciences, Inc. (the “Company” or “USANA”) issued a press release announcing its financial results for the fourth quarter and full-year ended December 29, 2018. The release also announced that the Company will post a document titled “Management Commentary, Results and Outlook” on the Company’s website and that executives of the company would hold a conference call with investors, to be broadcast over the World Wide Web and by telephone and provided access information, date and time for the conference call. The Company noted that the call will consist of brief remarks by the Company’s management team, before moving directly into questions and answers. A copy of the press release, and the Management Commentary, Results and Outlook, are furnished herewith as Exhibits to this Current Report on Form 8-K and are incorporated herein by reference. These documents will be posted on the Company’s corporate website, www.usana.com.
The information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document to the Securities Act of 1933, as amended. The furnishing of the information in this Current Report is not intended to, and does not, constitute a representation that such furnishing is required by Regulation FD or that the information this Current Report contains is material investor information that is not otherwise publicly available.
|
Item 2.02 |
Regulation FD Disclosure |
The information disclosed above under Item 2.02, as well as the exhibits attached under Item 2.02 below are incorporated herein by reference.
|
Item 2.02 |
Financial Statements and Exhibits. |
| (d) Exhibits | |
|
Exhibit No. |
Description |
| 99.1 |
Press release issued by USANA Health Sciences, Inc. dated February 5, 2019 (furnished herewith). |
|
99.2 |
Management Commentary, Results and Outlook provided by USANA Health Sciences, Inc. dated February 5, 2019 (furnished herewith). |
USANA HEALTH SCIENCES INC Exhibit
EX-99.1 2 a51936400ex99_1.htm EXHIBIT 99.1 Exhibit 99.1 USANA Health Sciences Reports Record Full-Year 2018 Results Record fiscal year net sales of $1.189 billion,…
To view the full exhibit click here
About USANA HEALTH SCIENCES, INC. (NYSE:USNA)
USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. It operates as a direct selling company in approximately two geographic regions: Americas and Europe, and Asia Pacific, which includes approximately three sub-regions: Southeast Asia Pacific, Greater China and North Asia. Its USANA Nutritionals Essentials product line includes vitamin and mineral supplements that provide a foundation of body nutrition for every age group. Its Foods product line includes low-glycemic meal replacement shakes and snack bars. Its Optimizers product line offers targeted supplements, which meets individual health and nutritional needs. Its Sense-beautiful science product line includes science-based, personal care products that support skin and hair. Its All Other product line includes materials and online tools that assists its network marketing system of independent distributors (Associates) in building their businesses and in marketing its products.
